Our group is currently translocating to the Chair for Pharmaceutical Biology at Friedrich-Alexander-University Erlangen. Press release
See our FAU webpage here.
September 2021 - Congrats to Adriely for publishing her manuscripts in Nanoscale
Interaction of myxobacteria-derived outer membrane vesicles with biofilms: antiadhesive and antibacterial effects - great job and very nice collarboration with Knut Drescher's group!
BIOGENIC NANOTHERAPEUTICS
We are the Junior Research Group Biogenic Nanotherapeutics (BION) at the Helmholtz Institute for Pharmaceutical Research Saarland and the Chair for Pharmaceutical Biology at Friedrich-Alexander University Erlangen.
Our aim is to engineer smart biomimetic drug carriers utilising principles established in nature. We are dedicated to using cutting-edge methodologies in nanoparticle formulation and imaging combined with tangible pharmaceutical know-how in the field of targeted drug delivery.
German Society for Extracellular Vesicles GSEV - the national network for scientists and professionals working in the field of exosomes, microvesicles and other cell-derived vesicles - more information
NEWS - Our lab featured on TV and in print - more here
FUHRMANN | LAB
Chair for Pharmaceutical Biology
Friedrich-Alexander University Erlangen
Department Biology
Staudtstr. 5
91058
Helmholtz-Centre for Infection Research
Helmholtz-Institute for Pharmaceutical Sciences Saarland (HIPS)
Saarland University Campus E8.1
66123 Saarbrücken
Germany
Our research is supported by the European Research Council and the NanoMatFutur programme from the Federal Ministry of Education and Research (BMBF). Project BEVA
Other funding schemes:
- Volkswagen Foundation
- DAAD
- Studienstiftung
- Marie-Curie Actions
- Phospholipid Research Center
- Saarland University
Druckversion 